STOCK TITAN

OCCLL Financials

OCCLL
Trailing 12 months to February 28, 2026
Revenue $64.1B +14.9% YoY
Net Income $16.2B +33.3% YoY
EPS (Diluted) $4.34 FY2025 annual
Free Cash Flow -$24.7B -525.6% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Feb 28, 2026 Reported Currency USD FYE May

Newest figures come from the 10-Q for Q3 FY2026, filed Mar 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the OCCLL SEC filings page.

OCCLL (OCCLL) reported $64.1B in revenue over the twelve months to Feb 28, 2026, up 14.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OCCLL FY2025

Rising operating profitability is being absorbed by a capital-spending surge, making reinvestment—not earnings—the dominant FY2025 cash mechanic.

In FY2025, operating cash flow of $20.8B nearly matched capital expenditures of $21.2B, showing that expansion consumed almost all internally generated cash. That left free cash flow at -$394M despite net income of $12.4B, so cash conversion weakened because accounting profit did not translate into cash after reinvestment.

Operating leverage improved: operating margin rose from 29.0% to 30.8% between FY2024 and FY2025. Net margin widened in parallel, implying the improvement reached the bottom line rather than being absorbed by operating, financing, or tax costs.

The balance sheet strengthened structurally as debt-to-equity fell from 15.2x to 7.2x while equity expanded, reducing leverage’s role in financing assets. Yet the FY2025 current ratio remained below 1.0x, leaving working-capital pressure even as longer-term capitalization improved.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

OCCLL does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
4/7

OCCLL passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.67x

For every $1 of reported earnings, OCCLL generates $1.67 in operating cash flow ($20.8B OCF vs $12.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
4.94x

OCCLL earns $4.94 in operating income for every $1 of interest expense ($17.7B vs $3.6B). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$17.2B
YoY+21.7%
QoQ+7.0%
5Y CAGR+11.3%
10Y CAGR+6.7%

OCCLL generated $17.2B in revenue in Q3 2026. This represents an increase of 21.7% from the same quarter a year earlier. Against the prior quarter it is up 7.0%.

Net Income
$3.7B
YoY+26.7%
QoQ-39.3%

OCCLL reported $3.7B in net income in Q3 2026. This represents an increase of 26.7% from the same quarter a year earlier. Against the prior quarter it is down 39.3%.

EPS (Diluted)
$1.27
YoY+24.5%
QoQ-39.5%

OCCLL earned $1.27 per diluted share (EPS) in Q3 2026. This represents an increase of 24.5% from the same quarter a year earlier. Against the prior quarter it is down 39.5%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
-$11.5B
YoY-16274.6%
QoQ-15.2%

OCCLL recorded an outflow of $11.5B in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 16274.6% from the same quarter a year earlier. Against the prior quarter it is down 15.2%.

Cash & Debt
$38.5B
YoY+120.9%
QoQ+99.9%
5Y CAGR+11.5%
10Y CAGR+9.5%

OCCLL held $38.5B in cash as of Q3 2026; long-term debt is not reported for that period.

Dividends Per Share
$0.50
YoY+25.0%
QoQ0.0%

OCCLL paid $0.50 per share in dividends in Q3 2026. This represents an increase of 25.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
2.88B
YoY+2.6%
QoQ+0.1%
5Y CAGR-0.1%
10Y CAGR-3.6%

OCCLL had 2.88B shares outstanding in Q3 2026. This represents an increase of 2.6% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Operating Margin
31.8%
YoY+1.0pp
QoQ+2.3pp

OCCLL's operating margin was 31.8% in Q3 2026, reflecting core business profitability. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.3 percentage points.

Net Margin
21.6%
YoY+0.9pp
QoQ-16.6pp

OCCLL's net profit margin was 21.6% in Q3 2026, showing the share of revenue converted to profit. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.

Return on Equity
9.7%
YoY-7.9pp
QoQ-10.8pp

OCCLL's ROE was 9.7% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 7.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 10.8 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending
$2.6B
YoY+7.3%
QoQ+1.8%

OCCLL invested $2.6B in research and development in Q3 2026. This represents an increase of 7.3% from the same quarter a year earlier. Against the prior quarter it is up 1.8%.

Share Buybacks
$0
YoY-100.0%

OCCLL repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Capital Expenditures
$18.6B
YoY+217.9%
QoQ+54.9%
5Y CAGR+114.1%
10Y CAGR+48.1%

OCCLL invested $18.6B in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 217.9% from the same quarter a year earlier. Against the prior quarter it is up 54.9%.

OCCLL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OCCLL quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$17.2B+21.7%$16.1B+14.2%$14.9B+12.2%$15.9B+11.3%$14.1B+6.4%$14.1B+8.6%$13.3B+6.9%$14.3B+3.3%
R&D Expenses$2.6B+7.3%$2.6B+3.6%$2.5B+8.0%$2.7B+19.3%$2.4B+8.1%$2.5B+11.0%$2.3B+4.1%$2.2B0.0%
SG&A Expenses$389.0M-0.3%$409.0M+5.7%$376.0M+5.0%$467.0M+15.9%$390.0M+3.4%$387.0M+3.2%$358.0M-8.9%$403.0M+0.8%
Operating Income$5.5B+25.4%$4.7B+12.1%$4.3B+7.2%$5.1B+9.1%$4.4B+16.2%$4.2B+16.5%$4.0B+21.1%$4.7B+13.2%
EBITDAN/AN/A$6.1B+12.7%N/AN/AN/A$5.4B+13.6%N/A
Interest Expense$1.2B+32.3%$1.1B+22.1%$923.0M+9.6%$978.0M+11.4%$892.0M+1.8%$866.0M-2.5%$842.0M-3.4%$878.0M-8.0%
Income Tax$695.0M+35.7%$207.0M-13.4%$500.0M+108.3%$726.0M+13.8%$512.0M+10.3%$239.0M+10.1%$240.0M+633.3%$638.0M+403.8%
Net Income$3.7B+26.7%$6.1B+94.7%$2.9B-0.1%$3.4B+9.0%$2.9B+22.3%$3.2B+25.9%$2.9B+21.0%$3.1B-5.3%
EPS (Basic)$1.29+22.9%$2.14+89.4%$1.04-1.9%N/A$1.05+20.7%$1.13+24.2%$1.06+19.1%N/A
EPS (Diluted)$1.27+24.5%$2.10+90.9%$1.01-1.9%N/A$1.02+20.0%$1.10+23.6%$1.03+19.8%N/A
Diluted Shares (Avg)2.91B+1.3%2.92B+1.8%2.91B+2.0%N/A2.87B+2.0%2.87B+1.8%2.85B+1.0%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

OCCLL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OCCLL quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$245.2B+52.0%$205.0B+38.1%$180.4B+25.1%$168.4B+19.4%$161.4B+17.7%$148.5B+10.5%$144.2B+5.5%$141.0B+4.9%
Current Assets$54.9B+82.2%$34.4B+46.2%$24.6B+6.8%$24.6B+9.0%$30.1B+43.0%$23.5B+21.8%$23.1B+4.1%$22.6B+7.4%
Cash & Equivalents$38.5B+120.9%$19.2B+75.9%$10.4B-1.6%$10.8B+3.2%$17.4B+83.6%$10.9B+32.7%$10.6B-8.6%$10.5B+7.1%
InventoryN/AN/AN/A$303.0M-9.3%N/AN/AN/A$334.0M+12.1%
Accounts Receivable$10.7B+33.1%$9.4B+15.4%$8.8B+10.2%$8.6B+8.7%$8.1B+10.3%$8.2B+20.2%$8.0B+23.0%$7.9B+13.9%
Goodwill$62.3B+0.2%$62.2B0.0%$62.2B-0.1%$62.2B0.0%$62.2B-0.1%$62.2B0.0%$62.2B+0.1%$62.2B0.0%
Total Liabilities$206.7B+42.9%$175.0B+29.9%$156.3B+17.2%$147.9B+11.8%$144.6B+10.0%$134.7B+3.3%$133.4B-0.7%$132.3B-0.8%
Current Liabilities$40.7B+37.5%$37.8B+30.1%$39.9B+24.4%$32.6B+3.5%$29.6B+19.0%$29.1B+19.0%$32.0B+26.4%$31.5B+36.6%
Non-Current Liabilities$165.5B+44.5%$136.7B+30.0%$115.9B+14.9%$114.7B+14.5%$114.5B+8.0%$105.2B-0.3%$100.9B-7.0%$100.2B-8.7%
Total Equity$38.5B+130.1%$30.0B+117.9%$24.2B+123.3%$20.5B+135.0%$16.7B+197.5%$13.7B+255.6%$10.8B+356.4%$8.7B+711.2%
Retained Earnings-$7.1B+59.2%-$9.4B+50.9%-$14.1B+32.9%-$15.5B+31.6%-$17.4B+29.2%-$19.0B+25.1%-$20.9B+20.8%-$22.6B+18.1%

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Long-Term Debt.

OCCLL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OCCLL quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$7.2B+20.5%$2.1B+58.4%$8.1B+9.6%$6.2B+1.2%$5.9B+8.4%$1.3B+811.9%$7.4B+6.5%$6.1B+7.7%
Depreciation & AmortizationN/AN/A$1.8B+28.2%N/AN/AN/A$1.4B-3.2%N/A
Stock-Based Compensation$1.3B+10.9%$1.2B-1.2%$1.1B+11.6%N/A$1.2B+14.3%$1.2B+13.7%$1.0B+18.6%N/A
Capital Expenditures$18.6B+217.9%$12.0B+203.1%$8.5B+269.2%$9.1B+224.5%$5.9B+250.2%$4.0B+267.6%$2.3B+75.3%$2.8B+46.3%
Free Cash Flow-$11.5B-16274.6%-$10.0B-273.9%-$362.0M-107.1%-$2.9B-189.0%$71.0M-98.1%-$2.7B-184.5%$5.1B-9.5%$3.3B-12.1%
Investing Cash Flow-$19.5B-227.0%-$7.7B-103.6%-$8.7B-215.3%-$9.2B-232.0%-$6.0B-235.2%-$3.8B-203.3%-$2.8B-77.0%-$2.8B-71.6%
Financing Cash Flow$31.5B+380.2%$14.5B+393.1%$210.0M+104.6%-$3.8B-67.7%$6.6B+366.3%$2.9B+228.4%-$4.6B-30.0%-$2.3B+6.8%
Dividends Paid$1.4B+28.4%$1.4B+28.4%$1.4B+28.1%$1.4B+27.3%$1.1B+1.8%$1.1B+1.7%$1.1B+1.1%$1.1B+1.8%
Share Buybacks$0-100.0%$0-100.0%$95.0M-36.7%$150.0M-1.3%$150.0M-66.7%$150.0M-66.7%$150.0M0.0%$152.0M+1.3%

OCCLL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

OCCLL quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin31.8%+1.0pp29.5%-0.6pp28.6%-1.3pp32.1%-0.7pp30.8%+2.6pp30.0%+2.0pp30.0%+3.5pp32.8%+2.9pp
Net Margin21.6%+0.9pp38.2%+15.8pp19.6%-2.4pp21.6%-0.5pp20.8%+2.7pp22.4%+3.1pp22.0%+2.6pp22.0%-2.0pp
Return on Equity9.7%-7.9pp20.5%-2.4pp12.1%-15.0pp16.8%-19.3pp17.5%-25.1pp22.9%-41.8pp27.1%-75.0pp36.1%-273.1pp
Return on Assets1.5%-0.3pp3.0%+0.9pp1.6%-0.4pp2.0%-0.2pp1.8%+0.1pp2.1%+0.3pp2.0%+0.3pp2.2%-0.2pp
Current Ratio1.35+0.3x0.91+0.1x0.62-0.1x0.750.0x1.02+0.2x0.810.0x0.72-0.2x0.71-0.2x
Debt-to-Equity5.37-3.3x5.84-4.0x6.47-5.9x7.23-8.0x8.65-14.7x9.80-23.9x12.33-44.3x15.20-109.0x
Asset Turnover0.070.0x0.080.0x0.080.0x0.090.0x0.090.0x0.090.0x0.090.0x0.100.0x
FCF Margin-66.8%-67.3pp-62.1%-43.1pp-2.4%-40.9pp-18.4%-41.4pp0.5%-28.1pp-19.0%-11.7pp38.5%-6.9pp23.0%-4.0pp

Not reported in any period shown, so not listed: Gross Margin.

Note: The current ratio is below 1.0 (0.75), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is OCCLL's annual revenue?

OCCLL (OCCLL) reported $57.4B in total revenue for fiscal year 2025. This represents a 8.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is OCCLL's revenue growing?

OCCLL (OCCLL) revenue grew by 8.4% year-over-year, from $53.0B to $57.4B in fiscal year 2025.

Is OCCLL profitable?

Yes, OCCLL (OCCLL) reported a net income of $12.4B in fiscal year 2025, with a net profit margin of 21.7%.

OCCLL (OCCLL) reported diluted earnings per share of $4.34 for fiscal year 2025. This represents a 17.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

OCCLL (OCCLL) had EBITDA of $23.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

OCCLL (OCCLL) had an operating margin of 30.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

OCCLL (OCCLL) had a net profit margin of 21.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, OCCLL (OCCLL) paid $1.70 per share in dividends during fiscal year 2025.

OCCLL (OCCLL) has a return on equity of 60.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

OCCLL (OCCLL) recorded an outflow of $394.0M in free cash flow during fiscal year 2025. This represents a -103.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

OCCLL (OCCLL) generated $20.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

OCCLL (OCCLL) had $168.4B in total assets as of fiscal year 2025, including both current and long-term assets.

OCCLL (OCCLL) invested $21.2B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

OCCLL (OCCLL) invested $9.9B in research and development during fiscal year 2025.

Yes, OCCLL (OCCLL) spent $600.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

OCCLL (OCCLL) had 2.81B shares outstanding as of fiscal year 2025.

OCCLL (OCCLL) had a current ratio of 0.75 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

OCCLL (OCCLL) had a debt-to-equity ratio of 7.23 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

OCCLL (OCCLL) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

OCCLL (OCCLL) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

OCCLL (OCCLL) has an earnings quality ratio of 1.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

OCCLL (OCCLL) has an interest coverage ratio of 4.94x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top